Related Experiment Video
Updated: May 11, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Stereotactic radiosurgery for spinal neoplasms: current status and future perspective.
1Department of Neurosurgery, Korea Institute of Radiological and Medical Science, Seoul, the Republic of Korea. cuk@kcch.re.kr
Journal of Neurosurgical Sciences
|May 17, 2013
Summary
Stereotactic radiosurgery (SRS) offers a safe and effective treatment for spinal tumors, significantly reducing pain and improving local control. This advanced radiation technique is a valuable option for managing spinal neoplasms.
Area of Science:
- Oncology
- Radiation Oncology
- Neurosurgery
Background:
- Stereotactic radiosurgery (SRS) is increasingly used for primary and metastatic spinal tumors.
- SRS utilizes high-dose, image-guided radiation in 1-5 fractions with conformal techniques.
- Its efficacy stems from hypofractionated radiation's radiobiological advantages and precise delivery.
Purpose of the Study:
- To review the principles of spinal SRS.
- To summarize the literature on SRS for spinal neoplasms.
Main Methods:
- Classification of spine SRS devices into CyberKnife and multileaf collimation (MLC) linear accelerator (LINAC) systems.
- Review of clinical data on SRS for primary and metastatic spinal tumors.
- Analysis of outcomes including pain reduction, local control, and complications.
Main Results:
- SRS is highly effective for spine metastases, with an 85% pain improvement rate and 90% local control.
- Benign spinal conditions like schwannoma and meningioma can also be treated.
- Complications are rare, with an estimated myelopathy risk of 0.4%.
Conclusions:
- Spinal SRS is an established, safe, and highly effective treatment for spinal tumors.
- Improved local control with SRS may enhance palliation and survival.
- SRS represents a significant advancement in managing spinal neoplasms.
